en · de · es · fr · pt
melanotan-2-notes.peptides6823.com › Data › Melanotan-2 Structure And Receptor Pharmacology — What the Evidence Shows

Melanotan-2 Structure And Receptor Pharmacology — What the Evidence Shows

By Editorial Desk · published 2026-07-21 · last reviewed 2026-08-01 · Data

peptide purity is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.

Melanotan-2 Structure and Receptor Pharmacology

Melanotan-2 is a synthetic cyclic heptapeptide designed as a structural analogue of alpha-melanocyte-stimulating hormone, the endogenous tridecapeptide that regulates pigment production. Two modifications distinguish it from the natural hormone: norleucine replaces methionine at the N-terminus, which limits oxidation, and a D-phenylalanine substitution raises receptor affinity. The ring is closed through an aspartate-lysine lactam bridge, giving the molecule a constrained conformation. The free base has a molecular mass near 1024 daltons, and commercial material is usually supplied as an acetate salt. It appears in the literature as a research peptide rather than an approved therapeutic agent.

Receptor studies place melanotan-2 among non-selective melanocortin agonists, binding MC1R, MC3R, MC4R and MC5R rather than a single subtype. Activation of MC1R on cutaneous melanocytes raises tyrosinase activity and shifts pigment synthesis toward eumelanin, which is darker and more photostable than pheomelanin. Central receptors, particularly MC4R, are associated with appetite suppression and with reported effects on sexual function. Because subtype selectivity is low, the same molecule engages pigment, metabolic and vascular pathways at once, and this breadth is a common explanation offered for the range of adverse events described in user reports.

Storage, Stability, and Analysis

Handling guidance for melanotan II follows general practice for small synthetic peptides rather than a product-specific monograph. Lyophilized powder is typically kept at minus twenty degrees Celsius or colder, protected from light and moisture, because warmth and humidity accelerate degradation. Once reconstituted, solutions are usually refrigerated and used within a short window, as hydrolysis and microbial growth both become concerns. Repeated freeze-thaw cycles are generally avoided. These conventions come from laboratory peptide chemistry and not from formal stability studies on this specific compound.

Analytical confirmation of identity relies on mass spectrometry, most often coupled to liquid chromatography. Reversed-phase high-performance liquid chromatography separates the peptide from related impurities and provides a purity estimate based on peak area. Electrospray ionization mass spectrometry then confirms the expected molecular mass, while tandem mass spectrometry can map the fragment sequence. For research-grade material, these two techniques together form the standard minimum. Purity figures reported by vendors are frequently not traceable to an independent laboratory.

Melanotan-2 at a glance

PropertyValueNotes
Molecular formulaC50H69N15O9Free base; salt forms add to total mass
Molecular massAbout 1024 daltonsCalculated for the free base
Structural classCyclic heptapeptideContains D-phenylalanine and norleucine
Parent hormoneAlpha-melanocyte-stimulating hormoneEndogenous tridecapeptide of 13 residues
Receptor profileNon-selective melanocortin agonistInteracts with MC1R, MC3R, MC4R and MC5R

Background and Receptor Mechanism

Melanotan II is a synthetic cyclic heptapeptide analog derived from the core sequence of alpha-melanocyte-stimulating hormone. Researchers at the University of Arizona synthesized it during the 1980s while studying pigmentation and appetite signaling. The compound is not an approved medicine in any major jurisdiction and appears mainly in laboratory and research-chemical settings. Its structure incorporates a lactam bridge between side chains, which constrains the ring and slows enzymatic breakdown relative to the natural hormone.

Melanotan II binds several melanocortin receptor subtypes rather than a single target. MC1R on melanocytes drives melanin synthesis, while MC3R and MC4R participate in energy balance, appetite, and sexual response pathways. This lack of selectivity explains why reported effects extend beyond skin darkening. Substitutions at positions four and seven, including norleucine and D-phenylalanine, increase potency and resistance to peptidases. Understanding which receptor mediates which effect remains an active area of investigation.

Related pages on this site

Regulatory Status and Literature Discussion

Melanotan-2 has not received marketing authorisation from major regulatory agencies for any therapeutic indication. Several jurisdictions classify it as a prescription-only medicine or a controlled substance when supplied for human use. Because approved products do not exist, material sold online usually sits outside pharmaceutical supply chains and formal quality oversight. Regulators have issued public notices describing the compound as unapproved. Enforcement varies, and the legal position differs between countries, which complicates any single general statement about its status.

Scientific discussion of Melanotan-2 spans pharmacology, dermatology, and public-health literature. Laboratory studies examine its receptor binding and cellular effects, while clinical reports describe outcomes observed after unregulated use. These two bodies of work differ in rigour and intent. Peer-reviewed trials of the compound as a medicine are limited, so much of the available information comes from case reports and surveillance data. Authors frequently note the gap between experimental findings and real-world use.

Background from the literature

Nitrogen fixation by industrial processes like the Frank–Caro process (1895–1899) and Haber–Bosch process (1908–1913) eased this shortage of nitrogen compounds, to the extent that half of global food production now relies on synthetic nitrogen fertilisers. At the same time, use of the Ostwald process (1902) to produce nitrates from industrial nitrogen fixation allowed the large-scale industrial production of nitrates as feedstock in the manufacture of explosives in the World Wars of the 20th century.

The first President of Cuba, Tomás Estrada Palma, was a Freemason. After his election in April 1902, he returned from exile to Cuba and went on a tour of the island's Masonic Lodges. On May 20, 1902, the Cuban flag was raised for the first time on its own, without the American Flag flying next to it. The next day, on May 21, General Máximo Gómez placed that same exact flag in a wooden chest and handed the chest to Grand Master José Fernández Pellón Castellanos, to ceremonially honor the sacrifices that Cuban Freemasons had made, and the efforts that Cuban Freemasonry had contributed to the creation of an independent Cuba. Freemasonry steadily grew across Cuba. New Masonic Temples were erected across the island, and a Masonic Band was created. Freemasons largely returned to the normal work of charity; schools were built, shoes were dispensed to children in need, an ambulance was given to a hospital, hurricane relief funds were gathered for Puerto Rico and other islands, medical procedures were funded, and a dental dispensary was created. Four entirely English-speaking Lodges were established in communities that had been established by American colonists to the island; Island Lodge in Havana, Landmark Lodge in Camagüey, Kane Lodge in Banes, and Santa Fe Lodge on the Isle of Pines. By 1953, there were 400 English-speaking members across these English language Lodges.

=== Operation Theater Complex === The Operation Theater Complex was completed with PKR 260 million and was finally inaugurated on the Saturday 27 April 2019 having four State-of-the-art Operation theaters with a total capacity of 60 beds of which 10 are in the surgical ICU.

Sources: en.wikipedia.org

Reference notes

At half-neutralization the ratio ⁠[A−]/[HA]⁠ = 1; since log(1) = 0, the pH at half-neutralization is numerically equal to pKa. Conversely, when pH = pKa, the concentration of HA is equal to the concentration of A−. The buffer region extends over the approximate range pKa ± 2. Buffering is weak outside the range pKa ± 1. At pH ≤ pKa − 2 the substance is said to be fully protonated and at pH ≥ pKa + 2 it is fully dissociated (deprotonated). If the pH is known, the ratio may be calculated. This ratio is independent of the analytical concentration of the acid. In water, measurable pKa values range from about −2 for a strong acid to about 12 for a very weak acid (or strong base). A buffer solution of a desired pH can be prepared as a mixture of a weak acid and its conjugate base. In practice, the mixture can be created by dissolving the acid in water, and adding the requisite amount of strong acid or base. When the pKa and analytical concentration of the acid are known, the extent of dissociation and pH of a solution of a monoprotic acid can be easily calculated using an ICE table.

=== Etymology === Proprioception is from Latin proprius, meaning "one's own", "individual", and capio, capere, to take or grasp. Thus to grasp one's own position in space, including the position of the limbs in relation to each other and the body as a whole. The word kinesthesia or kinæsthesia (kinesthetic sense) refers to movement sense, but has been used inconsistently to refer either to proprioception alone or to the brain's integration of proprioceptive and vestibular inputs. Kinesthesia is a modern medical term composed of elements from Greek; kinein "to set in motion; to move" (from PIE root *keie- "to set in motion") + aisthesis "perception, feeling" (from PIE root *au- "to perceive").

MOF pore characterizations {Designed metal-organic framework composites for metal-ion batteries and metal-ion capacitors/ Gaurav Tatrari, Rong An, Faiz Ullah Shah Coordination Chemistry Reviews, Volume 512, 215876} Hypothetical MOFs Database Archived 2019-02-19 at the Wayback Machine MOF physical property calculator

Sources: en.wikipedia.org

Notes from published material

Transworld Group is a multinational shipping and logistics company, based in Dubai, United Arab Emirates. It has business interests in shipping and logistics, aviation, supply chain management, and food processing, among others. Established in 1977 by R. Sivaswamy, the company has offices in the United Arab Emirates, Saudi Arabia, Oman, Sri Lanka, and multiple cities in India.

== Exhibition == Lindow Man is held in the collection of the British Museum in London, where his remains were first publicly displayed in July 1986 as part of the exhibition Archaeology in Britain. In 1997, they were moved to the museum's Iron Age gallery. His remains have also been loaned to other museums for temporary exhibitions. Manchester Museum displayed him in 1987, 1991 and from 19 April 2008 to 19 April 2009. The 2008–2009 exhibition, Lindow Man: A Bog Body Mystery, won the award for Best Archaeological Innovation at the 2010 British Archaeological Awards. His remains were subsequently exhibited at the Great North Museum in Newcastle upon Tyne from August to November 2009, before returning to the British Museum.

All sport in South Africa under apartheid was segregated by race, with separate clubs and governing bodies. Only white bodies were affiliated to the South African Olympic and Empire [later Commonwealth] Games Association (SAOEGA, later SAOCGA) so only white South Africans competed at the Olympic Games and the Empire (later Commonwealth) Games. The IOC under Avery Brundage regarded this as an internal matter for South Africa, and, committed to keeping politics and sports separate, took no action. From 1948, black athletes and their federations complained to the IOC about their exclusion, but were told to take the matter up with the SAOCGA. In the 1950s, NOCs from the Eastern Bloc led by the Soviet Union began to question this stance. With the decolonisation of Africa from the late 1950s, NOCs from newly independent states opposed to apartheid began affiliating to the IOC. However, the IOC itself was not representative of NOCs but rather a group of co-opted individuals, still mostly from First World countries. On the other hand, the international federations (IFs), the governing bodies of the Olympic sports, were quicker to give a voice to newer members.

Sources: en.wikipedia.org

Frequently asked questions

Is melanotan-2 approved for medical use?

No regulatory agency has authorised melanotan-2 as a medicine for any indication. It circulates mainly as a research chemical or through unregulated channels. As a result, identity, purity and content are not independently guaranteed.

How does melanotan-2 differ from melanotan-1?

Melanotan-1, also called afamelanotide, is a linear analogue with greater selectivity for MC1R and has received approval in some jurisdictions for a specific photosensitivity disorder. Melanotan-2 is cyclic, less selective, and reaches central receptors more readily. The two are often confused in online discussion despite different pharmacology and regulatory status.

What is the connection to alpha-MSH?

Alpha-MSH is an endogenous tridecapeptide derived from pro-opiomelanocortin. Melanotan-2 reproduces its core receptor-binding sequence inside a shortened, stabilised ring. The result is a molecule with a longer effective half-life and higher potency than the parent hormone.

How is the peptide usually stored?

The lyophilized powder is generally held at minus twenty degrees Celsius or below, away from light and moisture. Reconstituted solutions are typically refrigerated and used quickly. These practices derive from general peptide handling rather than a formal stability study.

Network